Tue.Jan 28, 2025

article thumbnail

FDA Approves Semaglutide to Reduce Kidney Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease

Pharmacy Times

The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.

FDA 157
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Chief among the questions raised by Monday's ambiguous memo are whether programs like Medicaid and SNAP as well as funding for clinical research, community health centers, suicide prevention and state infectious disease surveillance will see interruptions due to the pause.

142
142
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Hydroxychloroquine Enhances the Efficacy of Palbociclib, Letrozole Therapy in Patients With HR+, HER2– Metastatic Breast Cancer

Pharmacy Times

Endocrine therapy in combination with CDK4/6 inhibitors improves patients outcomes, but many still become treatment resistant.

139
139
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The National Community Pharmacists Association is warning the feds that independent pharmacists are likely to face significant financial hardship due to Medicare drug price negotiations.

126
126
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Grants Trastuzumab Deruxtecan Approval for Endocrine-Treated Patients With Metastatic HR+, HER2-Low Breast Cancer

Pharmacy Times

The antibody-drug conjugate shows efficacy in reducing disease progression risk and increasing progression-free survival in patients with HR+, HER2-low, or HER2-ultralow metastatic breast cancer.

FDA 126
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

CVS Health is rolling out a new customer app designed to make it simpler and more convenient for users to manage health benefits, pharmacy benefits and prescriptions.

105
105

More Trending

article thumbnail

Cebranopadol Shows Lower Abuse Potential Compared to Existing Pain Therapies

Drug Topics

A supratherapeutic dose of 1000 ug cebranopadol was significantly less likeable compared to 40 mg oxycodone when crushed and taken intranasally.

98
article thumbnail

Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials

Outsourcing Pharma

Novo Nordisks amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lillys Zepbound. Further trials are planned.

93
article thumbnail

FDA Approves Ozempic for Improving CKD Outcomes in Adults with T2D

Drug Topics

Ozempic is now the most broadly indicated glucagon-like peptide-1 receptor agonist across the pharmaceutical drug market.

FDA 98
article thumbnail

Is VR the answer to the great wait?

pharmaphorum

Bring your waiting experience to life with Virtual Reality (VR)! Discover how VR technology is revolutionising the way we pass the time and enhancing customer satisfaction.

82
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Secukinumab Demonstrates Real-World Efficacy in Treating Psoriatic Arthritis

Drug Topics

Researchers conducted a literature review of patients clinical experiences with using secukinumab to treat psoriatic arthritis.

98
article thumbnail

Investigators Find Causal Link Between Apolipoprotein A-I and COPD

Pharmacy Times

High-density lipoprotein cholesterol, total cholesterol, and apolipoprotein B did not have significant correlations with chronic obstructive pulmonary disease.

81
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities.

79
article thumbnail

AI in medical imaging company Quibim raises $50m

pharmaphorum

Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.

77
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Socioeconomic Inequities Have a Significant Impact on Treatment of Antimicrobial Resistant Infections

Pharmacy Times

Pharmacist-led interventions significantly improve antibiotic prescribing practices, optimize therapy, and improve patient outcomes.

73
article thumbnail

Bringing drugs to market has ‘never been more challenging,’ and pharma is learning to adapt

PharmaVoice

As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.

65
article thumbnail

Pharmacists Play a Critical Role in Treating Alzheimer Disease

Pharmacy Times

Identifying drug-related problems is a vital component of medication therapy management.

73
article thumbnail

AB2 Bio and Nippon Shinyaku enter Tadekinig alfa licensing deal

Pharmaceutical Technology

AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise Tadekinig alfa.

64
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Patients With Juvenile Dermatomyositis Treated With IVIG Had No Increased Risk of Thromboembolic Events

Pharmacy Times

These results provide a pediatric lens into the potential risk of thromboembolic events in patients with dermatomyositis.

65
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Friday evening, Epic filed a reply memo to support its motion to dismiss Particle Health's antitrust lawsuit. The company doubled down on its argument that Particle Health makes "fatally deficient claims" in its lawsuit and in its opposition to Epic's motion to dismiss.

63
article thumbnail

Pembrolizumab Plus Lenvatinib Combination Shows Mixed Results in Gastroesophageal Cancer

Pharmacy Times

The trial meets one of the studys dual primary endpoints of progression-free survival, but did not meet its other primary endpoint of overall survival.

65
article thumbnail

Manas AI bags $24.6 million to turbocharge drug discovery

Outsourcing Pharma

Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.

62
article thumbnail

Optimizing Cholesterol Management: Incorporating Injectable Lipid-Lowering Therapies

Pharmacy Times

Challenges include therapy gaps, nonadherence, and fragmented care.

65
article thumbnail

Veru shares plunge despite positive data in obesity trial

pharmaphorum

Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.

62
article thumbnail

Anti-Infective Treatment Strategies in Case of Brainstem Hemorrhage Complicated with Pneumonia

Pharmacy Times

This case study underscores the critical importance of pharmacists who can provide comprehensive consideration and exploration of the appropriate treatment plan.

65
article thumbnail

Sage rejects Biogen takeover and launches review

pharmaphorum

Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.

60
article thumbnail

Tyler M. Kiles, PharmD, MPH, BC-ADM, Discusses Embracing Pharmacy Research and Shaping Health Equity in Practice

Pharmacy Times

Kiles explores the impact of pharmacy research on health equity and education.

65
article thumbnail

How Dual-Eligible Special Needs Plans Affect Medicaid Spending

Pharmaceutical Commerce

A study explores dual-enrollment in these planscompared to other Medicare Advantage plans impacts North Carolinas Medicaid fee-for-service spending.

59
article thumbnail

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial

Pharmaceutical Technology

the company announced that its Phase III trial examining its gastroenteropancreatic tumour treatment, ITM-11, met its primary endpoint.

59
article thumbnail

Stopwatch starts on reviews of GSK's long-acting asthma drug

pharmaphorum

Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.

58
article thumbnail

Allakos cuts 75% of workforce after chronic hives trial failure 

Pharmaceutical Technology

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.

59
article thumbnail

Women in Science: Émilie Barré on her passion for applying data to real-world challenges

Outsourcing Pharma

Throughout her career, One2Treats milie Barr has focused on developing both the analytical and leadership aspects necessary for success in the field.

55
article thumbnail

GLP-1RA developer Metsera targets $289m IPO

Pharmaceutical Technology

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

59